Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020 May 8, 2020
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference Apr 29, 2020
Moleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team Apr 22, 2020
Moleculin to Host Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate Today Apr 16, 2020
